World's Best Scientists 2026 revealed!
Justin A. Ezekowitz

Justin A. Ezekowitz

D-Index & Metrics

Medicine

D-Index
92
Citations
77011
World Ranking
11054
National Ranking
442

Overview

Justin A. Ezekowitz is affiliated with the University of Alberta in Canada and has a significant body of work primarily in the field of Medicine, with a focus on Cardiology and Cardiovascular Medicine. Their research encompasses a broad range of topics related to heart failure, cardiovascular risk factors, and the treatment and management of diabetes and related metabolic conditions.

Their main fields of study include:

  • Medicine

The subfields of study where Justin A. Ezekowitz has contributed extensively are:

  • Cardiology and Cardiovascular Medicine
  • Endocrinology, Diabetes and Metabolism
  • Pulmonary and Respiratory Medicine
  • Economics and Econometrics
  • Hematology

Key topics covered in their research include:

  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Cardiac pacing and defibrillation studies
  • Diabetes Treatment and Management
  • Potassium and Related Disorders
  • Cardiac Arrhythmias and Treatments
  • Health Systems, Economic Evaluations, Quality of Life

Justin A. Ezekowitz has published in a variety of significant venues. The journals where their research appears most frequently are:

  • Journal of the American College of Cardiology
  • Journal of Cardiac Failure
  • Canadian Journal of Cardiology
  • JACC Heart Failure
  • European Journal of Heart Failure

Among the recent papers associated with their work are:

  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, 2021, European Heart Journal
  • Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction, 2020, New England Journal of Medicine
  • Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity, 2023, New England Journal of Medicine
  • Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes, 2024, New England Journal of Medicine
  • CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction, 2021, Canadian Journal of Cardiology

The scientist frequently collaborates with several researchers who appear repeatedly as co-authors. These include:

  • Javed Butler
  • Piotr Ponikowski
  • Carolyn S.P. Lam
  • Adriaan A. Voors
  • Adrian F. Hernandez

Best Publications

  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

    Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno

  • Apixaban versus Warfarin in Patients with Atrial Fibrillation

    Christopher B. Granger;John H. Alexander;Renato D. Lopes;Elaine M. Hylek

  • HFSA 2010 Comprehensive Heart Failure Practice Guideline.

    Lindenfeld J;Albert Nm;Boehmer Jp

  • Effect of nesiritide in patients with acute decompensated heart failure.

    C. M. O'Connor;R. C. Starling;A. F. Hernandez;P. W. Armstrong

  • Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure.

    Justin A. Ezekowitz;Finlay A. McAlister;Paul W. Armstrong

  • Vericiguat in Patients With Heart Failure and Reduced Ejection Fraction

    Paul W Armstrong;Burkert Pieske;Kevin J Anstrom;Justin Ezekowitz

  • Renal Insufficiency and Heart Failure Prognostic and Therapeutic Implications From a Prospective Cohort Study

    Finlay A. McAlister;Justin Ezekowitz;Marcello Tonelli;Paul W. Armstrong

  • Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review.

    Finlay A. McAlister;Justin Ezekowitz;Nicola Hooton;Ben Vandermeer

  • Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure

    Finlay A McAlister;Natasha Wiebe;Justin A Ezekowitz;Alexander A Leung

  • 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure.

    Justin A. Ezekowitz;Eileen O'Meara;Michael A. McDonald;Howard Abrams

  • Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.

    G. Michael Felker;Kevin J. Anstrom;Kirkwood F. Adams;Justin A. Ezekowitz

  • Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure

    Finlay A. McAlister;Justin A. Ezekowitz;Natasha Wiebe;Brian Rowe

  • The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.

    Justin Ezekowitz;Finlay A. McAlister;Karin H. Humphries;Colleen M. Norris

  • The Effects of Climate Change on Cardiac Health.

    Jonathan De Blois;Tord Kjellstrom;Stefan Agewall;Justin A. Ezekowitz

  • Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction.

    Justin A. Ezekowitz;Padma Kaul;Jeffery A. Bakal;Paul W. Armstrong

  • Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity

    Edith Pituskin;John R Mackey;Sheri Koshman;Davinder Jassal

  • Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.

    Justin A. Ezekowitz;Paul W. Armstrong;Finlay A. McAlister

  • Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial

    John R. Teerlink;John R. Teerlink;G. Michael Felker;John J. V. McMurray;Scott D. Solomon

  • N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).

    Ziyad Hijazi;Lars Wallentin;Agneta Siegbahn;Ulrika Andersson

  • The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial

    Roopinder K. Sandhu;Justin Ezekowitz;Ulrika Andersson;John H. Alexander

Frequent Co-Authors

Paul W. Armstrong
Paul W. Armstrong University of Alberta
Finlay A. McAlister
Finlay A. McAlister University of Alberta
Adrian F. Hernandez
Adrian F. Hernandez Duke University
Adriaan A. Voors
Adriaan A. Voors University Medical Center Groningen
Randall C. Starling
Randall C. Starling Cleveland Clinic
John J.V. McMurray
John J.V. McMurray University of Glasgow
G. Michael Felker
G. Michael Felker Duke University
Robert M. Califf
Robert M. Califf Duke University
Marco Metra
Marco Metra University of Brescia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine opens the door to numerous specialized fields. If you’re interested in food science and well-being, an online nutritionist degree can prepare you for jobs in dietetics, public health, or corporate wellness. This pathway enables you to study core human nutrition topics while benefiting from the flexibility of remote learning.

Healthcare management is another growing area, and online mha programs cahme accredited are highly respected for training future healthcare leaders. These programs are designed for working professionals who want to advance into administrative or executive roles within hospitals and healthcare systems.

For registered nurses looking to advance their credentials quickly, there are rn to bsn no clinical hours programs, letting RNs earn a bachelor’s degree with maximum flexibility and minimal disruption to their work schedule.

Doctorate-level nurses may consider short dnp programs to further their expertise and leadership opportunities in clinical practice or administration. These programs are tailored for fast-tracked career advancement and are available entirely online.

Best Scientists Citing Justin A. Ezekowitz

Trending Scientists

Recently Published Articles